Morris Kandinov LLP is representing an investor in an action against Forte Biosciences Inc.’s board for breaching its fiduciary duties by diluting stockholders’ voting power to protect incumbents’ positions.

Morris Kandinov LLP is representing investors in TuSumple Holdings Inc. in a consolidated litigation in Delaware.

After being sued, the board of trustees of the First Trust closed-end funds announced that they have “determined to rescind the control share provisions.”

Morris Kandinov LLP represents investors in connection with vote rigging in a closed-end fund trustee election.

Morris Kandinov LLP represents investors in a dispute over a SPAC’s remaining assets in a dissolution after a failed transaction resulted in a termination fee.

Matt Levine writes about the key issue raised by three new SPAC cases filed by Morris Kandinov LLP: “Who gets the cash: the public shareholders, or the sponsors?”

The court denies defendants’ motion to dismiss claims arising from a closed-end fund’s collapse and subsequent unfair merger.

Morris Kandinov LLP along with two other firms will handle litigation involving a significant decline in merger value caused by Anaplan’s management.

Two new cases being handled by Morris Kandinov LLP each involve a dispute over a break-up fee following a failed SPAC transaction.

A SPAC investor has sued in the Delaware Court of Chancery, claiming that the SPAC’s sponsor is attempting to pocket a $20 million breakup fee after a failed merger.